Fig. 1From: Review of biomarkers in systemic juvenile idiopathic arthritis: helpful tools or just playing tricks?Biomarker need in clinical context. Typical clinical sequence in systemic juvenile idiopathic arthritis (SJIA) from disease onset, diagnosis to clinical resolution and flare. Specific time points where there is a need for diagnostic and prognostic biomarkers are indicated. Diagnostic markers are indicated as follows: D1 SJIA versus other non-JIA conditions, D2 SJIA versus other JIA subtypes. Prognostic markers are indicated as follows: P1 prognostic for flare, P2 prognostic for increased disease activity, P3 prognostic for macrophage activation syndrome (MAS) or differentiating MAS from SJIA flare. Adapted from Hinze et al. 2015 [8]Back to article page